Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Positive PhIII can’t salvage Merck’s anacetrapib, now relegated to the scrap heap
Positive PhIII can’t salvage Merck’s anacetrapib, now relegated to the scrap heap
Positive PhIII can’t salvage Merck’s anacetrapib, now relegated to the scrap heap
Submitted by
admin
on October 11, 2017 - 11:05pm
Source:
Endpoints
News Tags:
Merck
Anacetrapib
clinical trials
CETP inhibitors
Headline:
Positive PhIII can’t salvage Merck’s anacetrapib, now relegated to the scrap heap
Do Not Allow Advertisers to Use My Personal information
